Immune Profiling and Sequencing of Canine B Cell Lymphoma
Purpose of the study:
To perform immune profiling and sequencing of Canine B Cell Lymphoma
To determine whether these mutations are recognized by the immune system
Ultimately to use this information to generate more effective immunotherapies for this and other cancers of dogs
Primary Eligibility Criteria:
Dogs with multicentric B cell lymphoma
Must be healthy enough for sedation and biopsy of the lymph node
Pre-enrollment: confirm diagnosis, lymphoma phenotyping, confirm that dog has not been treated previously
Week 1: blood collection and biopsy
Consent to biopsy and blood sampling
The study will cover costs of the study procedures.
There is a $500.00 credit applied to the VTH account of the patient
If you have further questions about any of our clinical trials, please submit an online consulting form. Your consult will then be directed to an appropriate oncology clinician. Requests are typically returned within 5 business days.